AKRO Stock Data and Insider Activity
AKRO - Akero Therapeutics, Inc. Common Stock Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
  
     
Chart and Financial Data provided by TradingView
Whale Activity

Recently reported position changes by institutional investors

Senate Trading

Recent trades by U.S. Senators

No data for this ticker
House Trading

Recent trades by U.S. Representatives

Date Rep. Type
11/8/2022 Christopher L. Jacobs Purchase
Insider Trading

Quarterly net insider trading by a company's directors and management

Corporate Flights

Flights by private jets registered to AKRO

No data for this ticker
Government Contracts

Federal grants, loans, and purchases. Click on a date for more info.

No data for this ticker
WallStreetBets